Health Canada Issues Actos Warning
Serving Alabama, Mississippi & Florida including Mobile, Pascagoula, Gulfport, Biloxi & Pensacola
Health Canada issued a warning on April 19, 2012 that Actos may increase the risk of bladder cancer. Pursuant to an agreement with the manufacturer, Takeda, the label to the drug will be changed to address the risk. As many of you will remember, the FDA issued a similar warning on June 15, 2011 which associated Actos with bladder cancer.